Role of endoscopic ultrasound in pancreatic cancer

References

• Yasuda K, Mukai H, Fujimoto S, Nakajima M, Kawai K. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest. Endosc.34(1), 1–8 (1988).
   PubMed Web of Science ®Google Scholar
• Rosch T, Lorenz R, Braig C et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest. Endosc.37(3), 347–352 (1991).
   PubMed Web of Science ®Google Scholar
• Chaya CT, Bhutani MS. Ultrasonography of the pancreas. 6. Endoscopic imaging. Abdom. Imaging32(2), 191–199 (2007).
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
   PubMed Web of Science ®Google Scholar
• Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann. Surg.244(1), 10–15 (2006).
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg.226(3), 248–257 (1997).
   PubMed Web of Science ®Google Scholar
• Rivadeneira DE, Pochapin M, Grobmyer SR et al. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann. Surg. Oncol.10(8), 890–897 (2003).
   PubMed Web of Science ®Google Scholar
• Raut CP, Grau AM, Staerkel GA et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J. Gastrointest. Surg.7(1), 118–126; discussion 127–118 (2003).
   PubMed Web of Science ®Google Scholar
• DeWitt J, Devereaux B, Chriswell M et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann. Intern. Med.141(10), 753–763 (2004).
   PubMed Web of Science ®Google Scholar
• Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am. J. Gastroenterol.99(5), 844–850 (2004).
   PubMed Web of Science ®Google Scholar
• Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom. Imaging32(5), 660–667 (2007).
   PubMedGoogle Scholar
• Rosch T, Schusdziarra V, Born P et al. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease. Am. J. Gastroenterol.95(9), 2261–2270 (2000).
   PubMed Web of Science ®Google Scholar
• Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am. J. Gastroenterol.97(6), 1386–1391 (2002).
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA, Varadarajulu S, Desai S et al. A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer. J. Gastrointest. Surg.11(7), 813–819 (2007).
   PubMed Web of Science ®Google Scholar
• Puli SR, Singh S, Hagedorn CH, Reddy J, Olyaee M. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest. Endosc.65(6), 788–797 (2007).
   PubMed Web of Science ®Google Scholar
• Ho JM, Eysselein VE, Stabile BE. The value of endoscopic ultrasonography in predicting resectability and margins of resection for periampullary tumors. Am. Surg.74(10), 1026–1029 (2008).
   PubMed Web of Science ®Google Scholar
• Bao PQ, Johnson JC, Lindsey EH et al. Endoscopic ultrasound and computed tomography predictors of pancreatic cancer resectability. J. Gastrointest. Surg.12(1), 10–16; discussion 16 (2008).
   PubMed Web of Science ®Google Scholar
• Yovino S, Darwin P, Daly B, Garofalo M, Moesinger R. Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. J. Gastrointest. Surg.11(1), 36–42 (2007).
   PubMed Web of Science ®Google Scholar
• Vilman P, Jacobsen GK, Henriksen FW, Hanke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest. Endosc.38, 172–173 (1992).
   PubMed Web of Science ®Google Scholar
• Paquin SC, Gariepy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest. Endosc.61(4), 610–611 (2005).
   PubMed Web of Science ®Google Scholar
• Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T. Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J. Gastroenterol.40(11), 1013–1023 (2005).
   PubMed Web of Science ®Google Scholar
• Abraham SC, Wilentz RE, Yeo CJ et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am. J. Surg. Pathol.27(1), 110–120 (2003).
   PubMed Web of Science ®Google Scholar
• Brand RE, Lerch MM, Rubinstein WS et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut56(10), 1460–1469 (2007).
   PubMed Web of Science ®Google Scholar
• Larghi A, Verna EC, Lecca PG, Costamagna G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin. Cancer Res.15(6), 1907–1914 (2009).
   PubMed Web of Science ®Google Scholar
• Canto MI. Screening and surveillance approaches in familial pancreatic cancer. Gastrointest. Endosc. Clin. N. Am.18(3), 535–553 (2008).
   PubMedGoogle Scholar
• Canto MI, Goggins M, Hruban RH et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin. Gastroenterol. Hepatol.4(6), 766–781 (2006).
   PubMed Web of Science ®Google Scholar
• Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann. Intern. Med.131(4), 247–255 (1999).
   PubMed Web of Science ®Google Scholar
• Kimmey MB, Bronner MP, Byrd DR, Brentnall TA. Screening and surveillance for hereditary pancreatic cancer. Gastrointest. Endosc.56(4 Suppl.), S82–S86 (2002).
   PubMed Web of Science ®Google Scholar
• Canto MI, Goggins M, Yeo CJ et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol.2(7), 606–621 (2004).
   PubMed Web of Science ®Google Scholar
• Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am. J. Gastroenterol.102(2), 430–438 (2007).
   PubMed Web of Science ®Google Scholar
• Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann. Surg.217(5), 447–455; discussion 456–447 (1993).
   PubMed Web of Science ®Google Scholar
• Michaels AJ, Draganov PV. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J. Gastroenterol.13(26), 3575–3580 (2007).
   PubMed Web of Science ®Google Scholar
• Levy MJ, Topazian MD, Wiersema MJ et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am. J. Gastroenterol.103(1), 98–103 (2008).
   PubMed Web of Science ®Google Scholar
• Chang KJ, Senzer N, Chung T. A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI). Gastrointest. Endosc.59 (2004).
   Web of Science ®Google Scholar
• Senzer N, Mani S, Rosemurgy A et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor a gene: a Phase I study in patients with solid tumors. J. Clin. Oncol.22(4), 592–601 (2004).
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Senzer N, Hecht JR et al. Long-term data for endoscopic ultrasound (EUS) and percutanous (PTA) guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC).Gastrointest. Endosc.63(5), AB93 (2006).
   Google Scholar
• Posner M, Chang KJ, Rosemurgy A et al. Multi-center Phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC). ASCO Annual Meeting Proceedings Part I. J. Clin. Oncol.25(18 Suppl.), 4518 (2007).
   Google Scholar
• Kothary N, Heit JJ, Louie JD et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J. Vasc. Interv. Radiol.20(2), 235–239 (2009).
   PubMed Web of Science ®Google Scholar
• Albashir S, Sawhney MS, Pleskow D et al. EUS-guided fiducial placement for cyberknife treatment of pancreatic cancer. Gastrointest. Endosc.67(5), AB223–AB224 (2008).
   Google Scholar
• Antillon MR, Chang KJ. Endoscopic and endosonography guided fine-needle aspiration. Gastrointest. Endosc. Clin. N. Am.10(4), 619–636 (2000).
   PubMedGoogle Scholar
• Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico–biliary tumors. Endoscopy38(1), 56–60 (2006).
   Google Scholar
• Affi A, Vazquez-Sequeiros E, Norton ID, Clain JE, Wiersema MJ. Acute extraluminal hemorrhage associated with EUS-guided fine needle aspiration: frequency and clinical significance. Gastrointest. Endosc.53(2), 221–225 (2001).
   PubMed Web of Science ®Google Scholar
• Gress F, Michael H, Gelrud D et al. EUS-guided fine-needle aspiration of the pancreas: evaluation of pancreatitis as a complication. Gastrointest. Endosc.56(6), 864–867 (2002).
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest. Endosc.63(4), 622–629 (2006).
   PubMed Web of Science ®Google Scholar
• Schima W, Fugger R, Schober E et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am. J. Roentgenol.179(3), 717–724 (2002).
   PubMed Web of Science ®Google Scholar
• Soriano A, Castells A, Ayuso C et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am. J. Gastroenterol.99(3), 492–501 (2004).
   PubMed Web of Science ®Google Scholar
• Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin. Gastroenterol. Hepatol.4(6), 717–725 (2006).
   PubMed Web of Science ®Google Scholar
• Arslan A, Buanes T, Geitung JT. Pancreatic carcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion. Eur. J. Radiol.38(2), 151–159 (2001).
   PubMed Web of Science ®Google Scholar
• Phoa SS, Reeders JW, Stoker J, Rauws EA, Gouma DJ, Lameris JS. CT criteria for venous invasion in patients with pancreatic head carcinoma. Br. J. Radiol.73(875), 1159–1164 (2000).
   PubMed Web of Science ®Google Scholar
• Valls C, Andia E, Sanchez A et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am. J. Roentgenol.178(4), 821–826 (2002).
   PubMed Web of Science ®Google Scholar
• O’Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am. J. Roentgenol.173(6), 1513–1518 (1999).
   PubMed Web of Science ®Google Scholar
• Wong JC, Lu DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin. Gastroenterol. Hepatol.6(12), 1301–1308 (2008).
   PubMed Web of Science ®Google Scholar
• Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology206(2), 373–378 (1998).
   PubMed Web of Science ®Google Scholar
• Trede M, Rumstadt B, Wendl K et al. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann. Surg.226(4), 393–405; discussion 405–397 (1997).
   PubMed Web of Science ®Google Scholar
• Ainsworth AP, Rafaelsen SR, Wamberg PA, Durup J, Pless TK, Mortensen MB. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography? Endoscopy35(12), 1029–1032 (2003).
   PubMed Web of Science ®Google Scholar
• Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J. Nucl. Med.42(5 Suppl.), S1–S93 (2001).
   PubMedGoogle Scholar
• Orlando LA, Kulasingam SL, Matchar DB. Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Aliment. Pharmacol. Ther.20(10), 1063–1070 (2004).
   PubMed Web of Science ®Google Scholar
• Lemke AJ, Niehues SM, Hosten N et al. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions – a prospective study with 104 patients. J. Nucl. Med.45(8), 1279–1286 (2004).
   PubMed Web of Science ®Google Scholar
• Heinrich S, Goerres GW, Schafer M et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann. Surg.242(2), 235–243 (2005).
   PubMed Web of Science ®Google Scholar
• Farma JM, Santillan AA, Melis M et al. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann. Surg. Oncol.15(9), 2465–2471 (2008).
   PubMed Web of Science ®Google Scholar
• Higashi T, Saga T, Nakamoto Y et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) –usefulness and limitations in “clinical reality”. Ann. Nucl. Med.17(4), 261–279 (2003).
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Yamamoto Y, Yokoe K et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann. Nucl. Med.19(6), 491–497 (2005).
   PubMed Web of Science ®Google Scholar
• Strobel K, Heinrich S, Bhure U et al. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J. Nucl. Med.49(9), 1408–1413 (2008).
   PubMed Web of Science ®Google Scholar
• Judah JR, Draganov PV. Intraductal biliary and pancreatic endoscopy: an expanding scope of possibility. World J. Gastroenterol.14(20), 3129–3136 (2008).
   PubMed Web of Science ®Google Scholar
• Reavis KM, Melvin WS. Advanced endoscopic technologies. Surg. Endosc.22(6), 1533–1546 (2008).
   PubMed Web of Science ®Google Scholar
• Mansfield SD, Scott J, Oppong K et al. Comparison of multislice computed tomography and endoscopic ultrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy. Br. J. Surg.95(12), 1512–1520 (2008).
   PubMed Web of Science ®Google Scholar
• Greene FL, American Joint Committee on cancer. AJCC Cancer Staging Manual. Springer, NY, USA (2002).
   Google Scholar
• Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas16(3), 396–401 (1998).
   PubMed Web of Science ®Google Scholar
• Schwarz M, Pauls S, Sokiranski R et al. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am. J. Surg.182(3), 243–249 (2001).
   PubMed Web of Science ®Google Scholar
• Seewald S, Omar S, Imazu H et al. Reliability of EUS in exclusion of pancreatic cancer – results of the Hamburg–Eppendorf study. Gastrointest. Endosc.63(5) (2006).
   Google Scholar
• Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest. Endosc.68(2), 237–242 (2008).
   PubMed Web of Science ®Google Scholar
• Bhutani MS, Gress FG, Giovannini M et al. The No Endosonographic Detection of Tumor (NEST) study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy36(5), 385–389 (2004).
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA, Varadarajulu S, Desai S, Wilcox CM. Value of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. J. Gastroenterol. Hepatol.23(4), 567–570 (2008).
   PubMed Web of Science ®Google Scholar
• Fusaroli P, Manta R, Fedeli P et al. The influence of endoscopic biliary stents on the accuracy of endoscopic ultrasound for pancreatic head cancer staging. Endoscopy39(9), 813–817 (2007).
   PubMed Web of Science ®Google Scholar
• Shami VM, Mahajan A, Sundaram V, Davis EM, Loch MM, Kahaleh M. Endoscopic ultrasound staging is adversely affected by placement of a self-expandable metal stent: fact or fiction? Pancreas37(4), 396–398 (2008).
   PubMed Web of Science ®Google Scholar
• Bettini N, Moutardier V, Turrini O et al. Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation. Gastroenterol. Clin. Biol.29(6–7), 659–663 (2005).
   PubMed Web of Science ®Google Scholar
• White RR, Paulson EK, Freed KS et al. Staging of pancreatic cancer before and after neoadjuvant chemoradiation. J. Gastrointest. Surg.5(6), 626–633 (2001).
   PubMed Web of Science ®Google Scholar
• Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest. Endosc.62(5), 728–736 (2005).
   PubMed Web of Science ®Google Scholar
• Hirche TO, Ignee A, Barreiros AP et al. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy40(11), 910–917 (2008).
   PubMed Web of Science ®Google Scholar
• Saftoiu A, Vilmann P, Gorunescu F et al. Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer. Gastrointest. Endosc.68(6), 1086–1094 (2008).
   PubMed Web of Science ®Google Scholar
• Colvin EK, Chang DC, Merrett ND, Kench JG, Biankin AV. Individualized therapy for pancreatic cancer. J. Gastroenterol. Hepatol.23(12), 1779–1782 (2008).
   PubMed Web of Science ®Google Scholar
• Biankin AV, Morey AL, Lee CS et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J. Clin. Oncol.20(23), 4531–4542 (2002).
   PubMed Web of Science ®Google Scholar
• Segara D, Biankin AV, Kench JG et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin. Cancer Res.11(9), 3587–3596 (2005).
   PubMed Web of Science ®Google Scholar
• Skalicky DA, Kench JG, Segara D et al. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev.15(10), 1941 (2006).
   PubMed Web of Science ®Google Scholar
• Murphy NC, Scarlett CJ, Kench JG et al. Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br. J. Cancer98(3), 537–541 (2008).
   PubMed Web of Science ®Google Scholar
• Chang DK, Merrett ND, Biankin AV. Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J. Gastroenterol. Hepatol.23(7 Pt 1), 1036–1045 (2008).
   PubMed Web of Science ®Google Scholar